These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

777 related items for PubMed ID: 16004803

  • 21. Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type.
    Leung SF, Chan AT, Zee B, Ma B, Chan LY, Johnson PJ, Lo YM.
    Cancer; 2003 Jul 15; 98(2):288-91. PubMed ID: 12872347
    [Abstract] [Full Text] [Related]

  • 22. [Detection of Epstein-Barr virus DNA in desquamative cell of nasopharyngeal carcinoma by polymerase chain reaction].
    Chen W, Chen Y, Ji C.
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1994 Jul 15; 29(6):327-9. PubMed ID: 7742020
    [Abstract] [Full Text] [Related]

  • 23. Epstein-Barr virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor origin.
    Ramayanti O, Juwana H, Verkuijlen SA, Adham M, Pegtel MD, Greijer AE, Middeldorp JM.
    Int J Cancer; 2017 Jan 01; 140(1):149-162. PubMed ID: 27600027
    [Abstract] [Full Text] [Related]

  • 24. [Latency of Epstein-Barr virus and its relationship to nasopharyngeal carcinomas].
    You S, Yao K, Cao Y.
    Zhonghua Zhong Liu Za Zhi; 1996 Jan 01; 18(1):23-6. PubMed ID: 8732106
    [Abstract] [Full Text] [Related]

  • 25. Comparison of two laboratory extraction techniques for the detection of Epstein-Barr virus in the saliva of nasopharyngeal carcinoma patients.
    Shan J, Pow EH, Tsang PC, Perera RA, Kwong DL.
    J Investig Clin Dent; 2014 May 01; 5(2):104-8. PubMed ID: 24574317
    [Abstract] [Full Text] [Related]

  • 26. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
    Mo WN, Tang AZ, Zhou L, Huang GW, Wang Z, Zeng Y.
    Chin Med J (Engl); 2009 May 20; 122(10):1173-8. PubMed ID: 19493466
    [Abstract] [Full Text] [Related]

  • 27. Differential expression of Epstein-Barr virus-encoded RNA and several tumor-related genes in various types of nasopharyngeal epithelial lesions and nasopharyngeal carcinoma using tissue microarray analysis.
    Fan SQ, Ma J, Zhou J, Xiong W, Xiao BY, Zhang WL, Tan C, Li XL, Shen SR, Zhou M, Zhang QH, Ou YJ, Zhuo HD, Fan S, Zhou YH, Li GY.
    Hum Pathol; 2006 May 20; 37(5):593-605. PubMed ID: 16647958
    [Abstract] [Full Text] [Related]

  • 28. Comparison of Epstein-Barr virus genotypes and clinicohistopathological features of nasopharyngeal carcinoma between Guilin, China and Fukuoka, Japan.
    Zhou Y, Nabeshima K, Koga K, Aoki M, Hayashi H, Hamasaki M, Iwasaki H.
    Oncol Rep; 2008 Jun 20; 19(6):1413-20. PubMed ID: 18497945
    [Abstract] [Full Text] [Related]

  • 29. Evaluation of nasal and nasopharyngeal swab collection for the detection of Epstein-Barr virus in nasopharyngeal carcinoma.
    Coghill AE, Wang CP, Verkuijilen SAWM, Yu KJ, Hsu WL, Middeldorp JM, Hildesheim A.
    J Med Virol; 2018 Jan 20; 90(1):191-195. PubMed ID: 28833336
    [Abstract] [Full Text] [Related]

  • 30. Hypermethylation of epithelial-cadherin gene promoter is associated with Epstein-Barr virus in nasopharyngeal carcinoma.
    Niemhom S, Kitazawa S, Kitazawa R, Maeda S, Leopairat J.
    Cancer Detect Prev; 2008 Jan 20; 32(2):127-34. PubMed ID: 18632221
    [Abstract] [Full Text] [Related]

  • 31. Detection of latent Epstein-Barr virus (EBV) DNA in paraffin sections of nasopharyngeal carcinomas expressing no EBV-encoded small RNAs using in situ PCR.
    Takeuchi H, Kobayashi R, Hasegawa M, Hirai K.
    Arch Virol; 1997 Jan 20; 142(9):1743-56. PubMed ID: 9672634
    [Abstract] [Full Text] [Related]

  • 32. [Comparison of Epstein-Barr virus in nasopharynx tissue and desquamatine cell for diagnosis of nasopharyngeal carcinoma].
    Sun Z, Xiao C, Jiang W, Feng X, Liu Y.
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Feb 20; 20(4):153-4. PubMed ID: 16711437
    [Abstract] [Full Text] [Related]

  • 33. Quantitative Epstein-Barr virus DNA analysis and detection of gene promoter hypermethylation in nasopharyngeal (NP) brushing samples from patients with NP carcinoma.
    Tong JH, Tsang RK, Lo KW, Woo JK, Kwong J, Chan MW, Chang AR, van Hasselt CA, Huang DP, To KF.
    Clin Cancer Res; 2002 Aug 20; 8(8):2612-9. PubMed ID: 12171892
    [Abstract] [Full Text] [Related]

  • 34. Prevalence of the Taiwan variant of the Epstein-Barr virus in nasopharyngeal carcinoma patients and normal individuals.
    Shu CH, Tu TY.
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Apr 20; 63(4):288-93. PubMed ID: 10820907
    [Abstract] [Full Text] [Related]

  • 35. [Prognostic impact of plasma Epstein-Barr virus DNA concentration on distant metastasis in nasopharyngeal carcinoma].
    Hou X, Zhang L, Zhao C, Li S, Lu LX, Han F, Shao JY, Huang PY.
    Ai Zheng; 2006 Jul 20; 25(7):785-92. PubMed ID: 16831265
    [Abstract] [Full Text] [Related]

  • 36. Role of Epstein-Barr virus DNA measurement in plasma in the clinical management of nasopharyngeal carcinoma in a low risk area.
    Kalpoe JS, Dekker PB, van Krieken JH, Baatenburg de Jong RJ, Kroes AC.
    J Clin Pathol; 2006 May 20; 59(5):537-41. PubMed ID: 16489178
    [Abstract] [Full Text] [Related]

  • 37. Detection of Epstein-Barr virus in nasopharyngeal carcinoma by in situ hybridization and polymerase chain reaction.
    Murono S, Yoshizaki T, Tanaka S, Takeshita H, Park CS, Furukawa M.
    Laryngoscope; 1997 Apr 20; 107(4):523-6. PubMed ID: 9111384
    [Abstract] [Full Text] [Related]

  • 38. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
    Ren Q, Sato H, Murono S, Furukawa M, Yoshizaki T.
    Laryngoscope; 2004 May 20; 114(5):855-9. PubMed ID: 15126743
    [Abstract] [Full Text] [Related]

  • 39. Identification of aberrant cell cycle regulation in Epstein-Barr virus-associated nasopharyngeal carcinoma by cDNA microarray and gene set enrichment analysis.
    Zhang W, Zeng Z, Zhou Y, Xiong W, Fan S, Xiao L, Huang D, Li Z, Li D, Wu M, Li X, Shen S, Wang R, Cao L, Tang K, Li G.
    Acta Biochim Biophys Sin (Shanghai); 2009 May 20; 41(5):414-28. PubMed ID: 19430707
    [Abstract] [Full Text] [Related]

  • 40. [Expression of CD25+ lymphocytes in nasopharyngeal carcinoma and its association with EBV infection].
    Liu W, Han HX.
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jan 20; 26(1):94-7. PubMed ID: 16495186
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 39.